|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Physiology, University of Arizona, Tucson, Arizona (W.M.S., S.H.W.); Concurrent Pharmaceuticals, Ft. Washington, Pennsylvania (S.E.); and Department of Pharmaceutical Sciences, University of Maryland at Baltimore, Baltimore, Maryland (C.C., P.W.S.)
Abstract
Organic cation transporters are important for the elimination of many drugs and toxins from the body. In the present study, substrate-transporter interactions were investigated in Chinese hamster ovary cells stably transfected with either the human or rabbit orthologs of the principal organic cation transporter in the kidney, OCT2. IC50 values, ranging from 0.04 µM to >3 mM, for inhibition of [14C]tetraethylammonium transport were determined for more than 30 structurally diverse compounds. Although the two OCT orthologs displayed similar IC50 values for some of these compounds, the majority varied by as much as 20-fold. Marked differences in substrate affinity were also noted when comparing hOCT2 to the closely related homolog hOCT1. These data suggest the molecular determinants of substrate binding differ markedly among both homologous and orthologous OCT transporters. The software package Cerius2 (Accelrys, San Diego, CA) was used to generate a descriptor-based, two-dimensional, quantitative structure-activity relationship (QSAR) to produce a model relating the affinity of hOCT2 to particular physicochemical features of substrate/inhibitor molecules (r2 = 0.81). Comparative molecular field analysis (Tripos, St. Louis, MO) was used to generate three-dimensional QSARs describing the structural basis of substrate binding to hOCT2 and rbOCT2 (q2 = 0.60 and 0.53, respectively, and each with r2 = 0.97). The quality of the models was assessed by their ability to successfully predict the inhibition of a set of test compounds. The current models enabled prediction of OCT2 affinity and may prove useful in the prediction of unwanted drug interactions at the level of the renal secretory process.
Received for publication July 8, 2004.
Accepted for publication January 3, 2005.
Address correspondence to: Dr. Stephen H. Wright, Department of Physiology, College of Medicine, University of Arizona, Tucson, AZ 85724. E-mail: shwright{at}u.arizona.edu
This article has been cited by other articles:
![]() |
G. A. Knudsen, Y. Cheng, R. K. Kuester, M. J. Hooth, and I. G. Sipes Effects of Dose and Route on the Disposition and Kinetics of 1-Butyl-1-methylpyrrolidinium Chloride in Male F-344 Rats Drug Metab. Dispos., November 1, 2009; 37(11): 2171 - 2177. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zolk, T. F. Solbach, J. Konig, and M. F. Fromm Functional Characterization of the Human Organic Cation Transporter 2 Variant p.270Ala>Ser Drug Metab. Dispos., June 1, 2009; 37(6): 1312 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-K. Lee, M. Reichold, B. Edemir, G. Ciarimboli, R. Warth, H. Koepsell, and F. Thevenod Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1504 - F1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cheng, S. H. Wright, M. J. Hooth, and I. G. Sipes Characterization of the Disposition and Toxicokinetics of N-Butylpyridinium Chloride in Male F-344 Rats and Female B6C3F1 Mice and Its Transport by Organic Cation Transporter 2 Drug Metab. Dispos., April 1, 2009; 37(4): 909 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kaler, D. M. Truong, A. Khandelwal, M. Nagle, S. A. Eraly, P. W. Swaan, and S. K. Nigam Structural Variation Governs Substrate Specificity for Organic Anion Transporter (OAT) Homologs: POTENTIAL REMOTE SENSING BY OAT FAMILY MEMBERS J. Biol. Chem., August 17, 2007; 282(33): 23841 - 23853. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, S. Zhang, M. Sorani, and K. M. Giacomini Transport of Paraquat by Human Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Family J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 695 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Pelis, Y. Dangprapai, T. M. Wunz, and S. H. Wright Inorganic mercury interacts with cysteine residues (C451 and C474) of hOCT2 to reduce its transport activity Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1583 - F1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Pelis, X. Zhang, Y. Dangprapai, and S. H. Wright Cysteine Accessibility in the Hydrophilic Cleft of Human Organic Cation Transporter 2 J. Biol. Chem., November 17, 2006; 281(46): 35272 - 35280. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Engel and J. Wang Interaction of Organic Cations with a Newly Identified Plasma Membrane Monoamine Transporter Mol. Pharmacol., November 1, 2005; 68(5): 1397 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, N. V. Shirahatti, D. Mahadevan, and S. H. Wright A Conserved Glutamate Residue in Transmembrane Helix 10 Influences Substrate Specificity of Rabbit OCT2 (SLC22A2) J. Biol. Chem., October 14, 2005; 280(41): 34813 - 34822. [Abstract] [Full Text] [PDF] |
||||